Table 2 Clinical outcomes of the patients with ipsilateral vs contralateral CIED and VA
Total | Ipsilateral | Contralateral | P value | |
|---|---|---|---|---|
(n = 42) | (n = 22) | (n = 20) | ||
Follow-up duration (months) | 101 (5–263) | 101 (20–263) | 83 (5–146) | 0.70 |
Mean (months) | 100 | 111 | 86 | |
Primary outcome | 24 (57) | 16 (73) | 8 (40) | 0.03 |
Any-cause mortality | 14 (33) | 9 (41) | 5 (25) | 0.28 |
Cardiac mortality | 7 (17) | 4 (18) | 3 (15) | > 0.99 |
Heart failure | 3 | 1 | 2 | |
Myocardial infarction | 1 | 1 | 0 | |
Recurrent VT | 2 | 1 | 1 | |
Cardiopulmonary failure | 1 | 1 | 0 | |
Septic shocka | 2 | 1 | 1 | |
Others | 5 | 4 | 1 | |
Systemic complications | 17 (41) | 12 (55) | 5 (25) | 0.051 |
Ipsilateral CV stenosisb | 7 (17) | 6 (27) | 1 (5) | 0.08 |
Contralateral CV stenosisc | 2 (5) | – | 2 (10) | NA |
Tricuspid regurgitationd | 10 (24) | 7 (32) | 3 (15) | 0.28 |
Secondary outcome | 22 (52) | 12 (55) | 10 (30) | 0.36 |
VA malfunction | 22 (52) | 12 (55) | 10 (30) | 0.36 |
Occlusion/stenosis | 16 | 7 | 9 | |
Infection | 1 | 1 | 0 | |
Others | 5 | 4 | 1 | |
CIED malfunction | 0 | 0 | 0 | NA |
Overall survival (months) | 117 (4–143) | 93 (7–143) | 136 (4–137) | 0.25 |
Mean (months) | 94 | 82 | 107 |